drugset / Trial / NCT02479074

The Utility of feNO in the Differential Diagnosis of Chronic Cough

NCT02479074

RandomizedFactorialOpen-labelDiagnostic

Summary

In this study the investigators wish to explore the difference in 24 hr. cough counts measured using the Hull Automated Cough Counter (HACC), from baseline and after two weeks treatment with either montelukast or prednisolone in patients with an NO measurement of ≥30 ppb at screening.

Timeline

Start
2016-01
Primary completion
2017-02-10
Completion
2017-03-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Montelukast Other / unclassified 10 mg Oral
Comparator Prednisolone Other / unclassified 20 mg

Indications

No indication recorded.